SCHEMBL724145

SCHEMBL724145

COc1cc(-c2cc3nccc(-c4ccc(C)c5ncccc45)c3o2)cc(OC)c1OC

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SYK P43405 5/20 0.47
PDE4C Q08493 3/20 0.43
PTGES O14684 1/20 0.42
ALOX5 P09917 1/20 0.42
BRD4 O60885 3/20 0.41
CYP1A1 P04798 3/20 0.41
CYP1B1 Q16678 3/20 0.41
JAK2 O60674 2/20 0.40
JAK1 P23458 2/20 0.40
TYK2 P29597 2/20 0.40
JAK3 P52333 2/20 0.40
CYP1A2 P05177 1/20 0.38
RPS6KA2 Q15349 1/20 0.37
GAK O14976 1/20 0.36
RIPK2 O43353 1/20 0.36
COQ8A Q8NI60 1/20 0.36
NLK Q9UBE8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL723027 0.90 PTGES (0.47) SYKPDE4CPTGESALOX5BRD4
SCHEMBL723616 0.85 PDE4C (0.53) SYKPDE4CPTGESALOX5BRD4
SCHEMBL723585 0.84 PDE4C (0.51) SYKPDE4CPTGESALOX5BRD4
SCHEMBL16817243 0.82 PDE4C (0.50) SYKPDE4CPTGESALOX5CYP1A1
SCHEMBL724141 0.82 PDE4C (0.48) SYKPDE4CPTGESALOX5BRD4
SCHEMBL10267652 0.81 CYP1A1 (0.54) SYKPDE4CPTGESALOX5CYP1A1
SCHEMBL724037 0.81 RPS6KA2 (0.43) SYKPDE4CPTGESALOX5BRD4
SCHEMBL723093 0.80 PDE4C (0.55) SYKPDE4CPTGESALOX5BRD4
SCHEMBL722271 0.80 PDE4C (0.48) SYKPDE4CPTGESALOX5BRD4
SCHEMBL722596 0.80 PDE4C (0.50) SYKPDE4CPTGESALOX5BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP claimed
EP-2609100-A2 FUROPYRIDINE DERIVATIVES Merck Patent GmbH (DE) 2013-07-03 EP claimed
CN-103052640-A Furopyridine derivatives MERCK PATENT GMBH 2013-04-17 CN claimed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO claimed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
EP-2609100-B1 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2015-06-24 EP disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-9006440-B2 Furopyridine derivatives MERCK PATENT GMBH (DE) 2015-04-14 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
US-20130225569-A1 FUROPYRIDINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-08-29 US disclosed
WO-2012025187-A2 FUROPYRIDINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225569-A1 FUROPYRIDINE DERIVATIVES SYK, FCGRT, SSB SYK 1/4885PDE4C 2858/4885PTGES 2267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.